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Resumo
Introdução: Dispositivos médicos como o 
cateter venoso central totalmente implantado 
(TIVAD) são cruciais no tratamento de pacientes 
submetidos a quimioterapia de longo prazo. 
Várias complicações foram documentadas, 
incluindo a migração da ponta do cateter.
Caso Clínico: Foi introduzido um TIVAD para 
realização de quimioterapia num paciente de 
64 anos de idade com diagnóstico de cancro 
do colon sigmoide. 17 meses após a introdução 
do TIVAD, o doente apresentou queixas de 
dor na região cervical direita, desde a clavícula 
à área mentoneana, durante uma sessão de 
quimioterapia. Foi realizado radiografia de 
tórax para confirmar a posição do TIVAD, 
demonstrando a migração da ponta do cateter 
para a veia jugular interna ipsilateral. O aumento 
da pressão intratorácica devido à tosse e vômito 
podem ser causas possíveis da migração da ponta 
do cateter.
Conclusão: A posição correta do TIVAD, que 
equivale à ponta do cateter localizado a 1 - 2 
cm abaixo da carina na radiografia de tórax, é 
crucial para prevenir a migração. A radiografia de 
tórax pode ser realizada para detetar a migração. 
Devem ser tomadas medidas para prevenir o 
aumento da pressão intratorácica.
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Abstract
Introduction: Totally implantable venous access 
devices (TIVAD) are crucial in the treatment of  
patients undergoing long-term chemotherapy. 
Various complications have been documented, 
including catheter tip migration. 
Case Description: A TIVAD was introduced 
to perform chemotherapy on a 64-year-old 
male with a diagnosis of  sigmoid colon cancer. 
17 months after the introduction of  TIVAD, 
our patient had complaints of  pain in the right 
cervical region, extending from the clavicle to 
the mandibular area, during a chemotherapy 
session. Chest X-ray was required to confirm 
the position of  TIVAD, demonstrating catheter 
tip migration to the ipsilateral internal jugular 
vein. Increased intrathoracic pressure due to 
cough and vomiting remains a possible cause for 
catheter tip migration.
Conclusion: the correct position of  TIVAD, 
meaning the tip of  the catheter located 1-2 
cm below the carina in chest X-ray, is crucial 
to prevent migration. Chest X-ray could be 
performed to detect migration. Measures to 
prevent increased intrathoracic pressure should 
be taken.
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Radiological Case Report / Caso Clínico
Introduction
Venous access is crucial in the treatment of  patients undergoing 
long-term therapy, such as chemotherapy, prolonged antibiotic 
therapy and during prolonged use of  parenteral nutrition.1-3 
Totally implantable venous access devices (TIVAD) are a good 
option as they improve the quality of  life in these patients.4
Although the use of  TIVAD has many advantages, various 
complications have been documented, including catheter tip 
migration, which occurs in about 0% to 4,3%.1,4-6 In more 
than 50% of  the cases, the catheter tip migrates to the internal 
jugular vein.2
Mechanisms generating traction forces on the catheter are 
pointed out to be the main causes for migration.1,2 Complications 
might be of  devastating outcome. It is therefore important to 
adopt preventive measures and cautious monitoring, to avoid 
and detect catheter tip migration, such as performing chest 
X-ray confirming a correct position of  the catheter after 
its introduction, as well as avoiding increased intrathoracic 
pressure.2,3 Preventive measures can be used early to avoid 
situations like cough and vomiting. Potentially treatable 
causes should be investigated and treated as soon as 
possible.
We report a case of  spontaneous catheter tip migration 
of  TIVAD to the ipsilateral internal jugular vein in an 
oncologic patient.
Case Description
A 64-year-old male with a diagnosis of  sigmoid colon cancer 
underwent left hemicolectomy in June 2015 (pT4aN2bM1b 
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R0). After surgery, a TIVAD was introduced to perform 
palliative chemotherapy (FOLFOX 6 regimen) (Fig. 1A). 
The patient performed six sessions of  FOLFOX 6 
chemotherapy, being the last session in March 2016. 
In September 2016, cancer progression is verified by 
the presence of  metastases in the liver and peritoneal 
carcinomatosis. Thereafter, chemotherapy was resumed, 
this time under FOLFIRI regimen. During the periods 
in which TIVAD was not used, routine clinical practice 
guidelines were followed to ensure patency of  the catheter 
lumen.7 They included aspiration, yielding blood contents, 
as well as locking with sterile heparinized saline solution by 
pulsatile and positive pressure flushing every four weeks.7
In March 2017, and after completing 10 sessions of  
FOLFIRI chemotherapy regimen, by decision of  
Oncology department, regimen was changed to FOLFOX 
6. There was no pause between the two chemotherapy 
regimens. During the first session, in April 2017, our 
patient had complaints of  pain in the right cervical region, 
extending from the clavicle to the mental area, during 
the first chemotherapy cycle. Neither edema nor other 
inflammatory signs were present. Prior to its use, catheter 
function was verified and demonstrated by aspirating blood 
without any resistance, confirming its patency. Chest X-ray 
was required to confirm the position of  TIVAD, and in 
this case, presented catheter tip migration to the ipsilateral 
internal jugular vein (Fig. 1C). Additionally, thrombosis of  
the vein was confirmed by doppler-ultrasound.
Literature differs about the presence of  symptoms in 
catheter tip migration. According to studies performed 
by Wu et al.,2 100% of  the patients were shown to be 
asymptomatic in association with catheter tip migration; 
the aberrant position was rather verified in routine chest 
X-ray at follow-up visits.
On the contrary, Fan et al.,1 showed that the occurrence 
of  a distal TIVAD portion located in a smaller caliber vein 
can cause complications such as neck pain, phlebitis or 
thrombosis. 
After reviewing the current clinical file, we found that 
our patient had visited the emergency room twice, due to 
cough, nausea and vomiting. Chest X-ray was performed, 
demonstrating an incorrect position of  the distal portion 
of  TIVAD, yet without total migration to the ipsilateral 
internal jugular vein (Fig. 1B). Nothing was recorded about 
the incorrect position of  the distal portion of  TIVAD, 
wherefore it is assumed that it was not observed. Thus, 
this demonstrates that regular follow-ups including chest 
X-ray, for as long as the TIVAD resides in a patient, might 
be an option.8 There is very scant literature addressing this 
Figure 1 – Chest X-ray: A (September 2015) – confirming the correct position, after TIVAD was introduced; B (August 2016) – during emergency 
room, due to cough, nausea and vomiting; C (April 2017) – after patient presented symptoms during a chemotherapy session; → : catheter tip position.
matter, therefore cost-effectiveness studies are required to 
support the use of  chest X-ray as a follow-up exam, as well 
as to determine the interval of  its use. We suggest chest 
X-ray when there is malfunctioning of  the TIVAD or when 
the patient presents related symptomatology.
Risk factors for catheter tip migration include an incorrect 
position of  TIVAD, changing from supine to erect position 
which may move the catheter approximately 20 mm, 
increased intrathoracic pressure, “jet effect” caused by a 
high perfusion flow, and/or heart dysfunction.1,2,9 Wu et al.2 
did not find any association between gender and catheter 
tip migration after performing studies using a multivariable 
logistic regression analysis, involving factors like age, 
gender, cancer type, position of  the catheter and type of  
port.
Heart dysfunction can be a risk factor for catheter tip 
migration.2 Our patient did have cardiac surgery when 
undergoing a coronary artery bypass grafting in 2009, 
which could have been an explanation for the catheter tip 
migration, however an echocardiogram performed in 2017, 
demonstrated normal structure and function of  the right 
heart.
The correct position of  TIVAD is still disputed. Some 
authors support it to be in the border between superior 
vena cava - right atrium, which would coincide with the 
tip of  the catheter being positioned 1 – 2 cm below the 
carina in chest X-ray (Fig. 2A).2 An incorrect position 
of  TIVAD, when the distal portion is located above the 
carina, therefore, increases risk of  migration.2 Wang et 
al.6 also demonstrates that an incorrect tip position is an 
independent risk factor for premature catheter extraction 
after adjustment for gender, cancer type and implantation 
position. Regarding our patient, it is demonstrated in figure 
1A that the catheter has a correct position and is therefore 
unlikely to be the cause for migration. In our institution, we 
routinely perform chest X-ray after introducing a TIVAD. 
Hence, as mentioned above, chest X-ray is an effective 
method for confirming the position, and potentially 
verify and correct possible acute complications such as 
pneumothorax and hemothorax.7
Wu et al.2 also studied the association between diseases and 
catheter migration and found one with lung cancer. This 
may be due to cough associated with lung cancer, which 
in turn increases intrathoracic pressure.1,2,10 When there is 
an increased intrathoracic pressure, a force is exerted on 
the horizontal portion of  the catheter, causing migration 
of  the medial portion (Fig. 2B).2 In our patient, cough and 
vomiting, as they increase intrathoracic pressure, remain a 
possible cause for catheter tip migration. 
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We suggest performing a chest X-ray to detect migration, 
when there is malfunctioning of  the TIVAD or when the 
patient presents related symptomatology.
All strategies should be taken to avoid an increased 
intrathoracic pressure. Preventive measures can be used 
early to avoid situations like cough and vomiting. Potentially 
treatable causes should be investigated and treated as soon 
as possible.
It is important to fully assess the patient in any situation, 
yet specifically, in patients with a TIVAD, it is important 
to locate the position of  the catheter. This should be 
conducted every time a chest x-ray is warranted for any 
other investigation.
In our patient, after catheter tip migration and thrombosis 
of  the vein were confirmed, TIVAD was extracted and 
a new one was placed through the contralateral internal 
jugular vein and treatment with new oral anticoagulants 
was implemented.
Conclusions
After introducing a TIVAD, its position should be 
evaluated using chest X-ray. Major attention should be paid 
to the placement of  the distal portion of  the catheter and 
potential acute complications, such as pneumothorax and 
hemothorax, should be assessed.
Figure 2 – A – illustration of  the correct 
position of  the tip of  catheter; B - illustration 
of  the force exerted on the horizontal portion 
of  the catheter with increased intrathoracic 
pressure.
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